21 NCAC 16U .0103         REPORTS FROM THE CONTROLLED SUBSTANCES REPORTING SYSTEM

(a)  Pursuant to G.S. 90-113.74(b1)(2), the Department of Health and Human Services (DHHS) may report to the Board information regarding the prescribing practices of those dentists who have issued:

(1)           at least 10 prescriptions for an opioid with at least 75 morphine milligram equivalents per day;

(2)           a benzodiazepine and an opioid to at least five patients where the patient's prescriptions overlap for at least two days; or

(3)           at least five "atypical prescriptions," which is defined as either:

(A)          medications classified as a stimulant, muscle relaxant, or hypnotic; or

(B)          at least 120 doses of an opioid or benzodiazepine.

(b)  Pursuant to G.S. 90-113.74(b1)(2), DHHS may report to the Board information regarding the prescribing practices of those dentists who have had a patient death due to opioid poisoning where the dentist prescribed 30 or more tablets of an opioid to the patient within 60 days of the patient's death.

(c)  Pursuant to G.S. 90-113.74(c)(7), DHHS may submit reports to the Board upon the Board's request for information regarding the prescribing practices of specific dentists, containing the information described in G.S. 90-113.73(b).

(d)  The reports and communications between DHHS and the Board shall remain confidential pursuant to G.S. 90-41 and G.S. 90-113.74.

History Note:        Authority G.S. 90-41; 90-48; 90-113.74;

Eff. July 1, 2015;

Pursuant to G.S. 150B-21.3A, rule is necessary without substantive public interest Eff. January 9, 2018;

Amended Eff. March 1, 2022.